We have been led like lambs to slaughter by a CEO who will not let anyone stand up to him. If anyone on the board disagrees or questions him on any of this actions they quickly depart with a very nice thank you.
Very few small cap companies like PAR ever make it to market and are swallowed up by large pharmaceutical at a discount and the CEO is usually the only person to get a windfall.
Stupidly I thought PAR was different and have been totally shafted by a masters.
Ann: PAR Successful Placement and Fully Underwritten ANREO, page-85
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 22.5¢ | $186.1K | 801.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 33599 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 65498 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |